Alain Gadisseur

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Flora Peyvandi, Roberta Palla, Marzia Menegatti et al. · Journal of Thrombosis and Haemostasis · 2012 · 498 citations · Full text

Medicine, Clinical Sciences, Hematology +15

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo Van Tendeloo, Ann Van de Velde, Ann Van Driessche et al. · Proceedings of the National Academy of Sciences · 2010 · 372 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille, Ann L. Van de Velde, Evelien Smits et al. · Blood · 2017 · 233 citations · Full text

Medicine, Immunology, Oncology +15

Comparison of the Quality of Oral Anticoagulant Therapy Through Patient Self-management and Management by Specialized Anticoagulation Clinics in the Netherlands

Alain Gadisseur, W. G. M. Breukink-Engbers, F.J.M. van der Meer et al. · Archives of Internal Medicine · 2003 · 119 citations

Medicine, Internal Medicine, General Internal Medicine +15

Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life

Alain Gadisseur, Ad A. Kaptein, W. G. M. Breukink-Engbers et al. · Journal of Thrombosis and Haemostasis · 2004 · 111 citations · Full text

Medicine, Pharmacotherapy, Self-management Support +10